Federated Computational Graph for Privacy-Preserving Oncology Planning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current AI-driven systems for oncological therapy lack the ability to integrate cross-species adaptations, oncological biomarkers, and environmental response data while maintaining data privacy, leading to inefficiencies in coordinating large-scale genomic interventions and real-time spatiotemporal analysis, which are crucial for effective cancer treatment.
Innovation Solution
A federated distributed computational graph platform with advanced multi-expert integration and adaptive uncertainty quantification, enabling secure cross-institutional collaboration by integrating oncological biomarkers, multi-scale imaging, and environmental response data, while maintaining privacy through token-space communication and multi-level uncertainty quantification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Power
If distributed computing solutions are used for multi-scale biological analysis, then computational capability is improved, but data privacy and security across institutions deteriorate
Solution Approach 1:
The system segments the centralized computational model into distributed local models across multiple institutions. Each institution trains and maintains its own local AI model on its private data, while only model parameters and gradients are shared through secure federated learning protocols. This segmentation enables computational power to be distributed across institutions without centralizing sensitive biological data, thus improving computational capability while preserving data privacy.
2Measurement precision
If real-time spatiotemporal analysis is implemented for tumor evolution tracking, then treatment precision is improved, but system complexity and data integration requirements worsen
Solution Approach 1:
The patent introduces a federated learning intermediary layer that mediates between diverse data sources (imaging, genomics, electronic health records) and the analytical models. This intermediary handles data standardization, privacy-preserving computation, and coordinated training across institutions, thereby enabling real-time spatiotemporal analysis for precise tumor evolution tracking without requiring direct integration of complex heterogeneous data systems.
3Adaptability or versatility
If cross-institutional collaboration is enabled for genomic interventions, then research versatility is improved, but data security and regulatory compliance worsen
Solution Approach 1:
Instead of sharing actual sensitive genomic data across institutions, the system creates and shares copies in the form of trained model parameters, gradients, and synthetic data representations. These copies enable cross-institutional research collaboration and genomic intervention planning while the original sensitive data remains securely localized at each institution, thus improving research versatility without compromising data security or regulatory compliance.
Data Source
AI summary
A federated distributed computational system enables secure oncological therapy optimization through multi-expert integration and advanced uncertainty quantification. The system implements a multi-expert integration framework that coordinates domain-specific knowledge through token-space communication for precision oncological treatment, while maintaining secure cross-institutional data exchange. The architecture coordinates multi-scale spatiotemporal synchronization across computational nodes, with each node containing local processing capabilities for fluorescence-guided imaging, uncertainty quantification, and expert knowledge integration. Through a distributed graph architecture, the system enables advanced fluorescence imaging with wavelength-specific targeting, multi-level uncertainty estimation combining epistemic and aleatoric approaches, and multi-scale tensor-based integration with adaptive dimensionality control. The system implements light cone search and planning for adaptive treatment strategy optimization, enabling medical institutions and research organizations to collaborate on complex oncological therapy projects while maintaining strict data privacy controls.


